Together, our results indicate that ectopic HAT‐L4 expression is a pathological mechanism in AML and that HAT‐L4 may be used as a cell surface marker for AML blast detection and targeting. The gene discussed is TMPRSS11D; the disease is acute myeloid leukemia.